CN111440857B - 用于无创胚胎植入前遗传性检测的方法 - Google Patents
用于无创胚胎植入前遗传性检测的方法 Download PDFInfo
- Publication number
- CN111440857B CN111440857B CN202010164460.3A CN202010164460A CN111440857B CN 111440857 B CN111440857 B CN 111440857B CN 202010164460 A CN202010164460 A CN 202010164460A CN 111440857 B CN111440857 B CN 111440857B
- Authority
- CN
- China
- Prior art keywords
- amplification
- detection
- embryo
- culture solution
- primer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 46
- 238000000034 method Methods 0.000 title claims abstract description 43
- 230000002068 genetic effect Effects 0.000 title claims abstract description 21
- 210000001161 mammalian embryo Anatomy 0.000 title claims description 35
- 238000002513 implantation Methods 0.000 title claims description 9
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 51
- 230000003321 amplification Effects 0.000 claims abstract description 49
- 210000002459 blastocyst Anatomy 0.000 claims abstract description 39
- 108020004414 DNA Proteins 0.000 claims abstract description 31
- 210000000349 chromosome Anatomy 0.000 claims abstract description 31
- 238000013412 genome amplification Methods 0.000 claims abstract description 30
- 230000008774 maternal effect Effects 0.000 claims abstract description 21
- 238000012163 sequencing technique Methods 0.000 claims abstract description 16
- 230000032692 embryo implantation Effects 0.000 claims abstract description 15
- 230000002159 abnormal effect Effects 0.000 claims abstract description 6
- 108091092878 Microsatellite Proteins 0.000 claims abstract description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 30
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 11
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 10
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 10
- 238000012360 testing method Methods 0.000 claims description 10
- 230000009089 cytolysis Effects 0.000 claims description 8
- 239000002773 nucleotide Substances 0.000 claims description 8
- 125000003729 nucleotide group Chemical group 0.000 claims description 8
- 102000004317 Lyases Human genes 0.000 claims description 7
- 108090000856 Lyases Proteins 0.000 claims description 7
- 238000007619 statistical method Methods 0.000 claims description 5
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 4
- 108010067770 Endopeptidase K Proteins 0.000 claims description 4
- 229920004890 Triton X-100 Polymers 0.000 claims description 4
- 239000013504 Triton X-100 Substances 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 238000003205 genotyping method Methods 0.000 claims description 4
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 claims 1
- 238000004458 analytical method Methods 0.000 claims 1
- 239000000243 solution Substances 0.000 abstract description 65
- 210000004027 cell Anatomy 0.000 abstract description 23
- 239000011259 mixed solution Substances 0.000 abstract description 15
- 208000036878 aneuploidy Diseases 0.000 abstract description 12
- 231100001075 aneuploidy Toxicity 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 7
- 238000005457 optimization Methods 0.000 abstract description 7
- 230000005764 inhibitory process Effects 0.000 abstract description 4
- 238000012300 Sequence Analysis Methods 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 abstract description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 34
- 238000001574 biopsy Methods 0.000 description 20
- 238000006243 chemical reaction Methods 0.000 description 17
- 239000011324 bead Substances 0.000 description 16
- 238000005516 engineering process Methods 0.000 description 14
- 239000000047 product Substances 0.000 description 12
- 230000008439 repair process Effects 0.000 description 12
- 239000012531 culture fluid Substances 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 8
- 239000008367 deionised water Substances 0.000 description 8
- 229910021641 deionized water Inorganic materials 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 210000002257 embryonic structure Anatomy 0.000 description 7
- 238000005070 sampling Methods 0.000 description 7
- 238000012408 PCR amplification Methods 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 230000010355 oscillation Effects 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 230000005856 abnormality Effects 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 210000002503 granulosa cell Anatomy 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 238000011109 contamination Methods 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 239000006166 lysate Substances 0.000 description 4
- 229910001629 magnesium chloride Inorganic materials 0.000 description 4
- 210000000287 oocyte Anatomy 0.000 description 4
- 210000002993 trophoblast Anatomy 0.000 description 4
- 102000053602 DNA Human genes 0.000 description 3
- 102000012410 DNA Ligases Human genes 0.000 description 3
- 108010061982 DNA Ligases Proteins 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000005138 cryopreservation Methods 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 230000009027 insemination Effects 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 230000001850 reproductive effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 210000000143 trophectoderm cell Anatomy 0.000 description 3
- 108091036333 Rapid DNA Proteins 0.000 description 2
- 206010000210 abortion Diseases 0.000 description 2
- 231100000176 abortion Toxicity 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000001109 blastomere Anatomy 0.000 description 2
- 238000007664 blowing Methods 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 230000004720 fertilization Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002493 microarray Methods 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 239000010902 straw Substances 0.000 description 2
- 239000010414 supernatant solution Substances 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 208000031404 Chromosome Aberrations Diseases 0.000 description 1
- 208000009701 Embryo Loss Diseases 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 208000007466 Male Infertility Diseases 0.000 description 1
- 101150032520 STR gene Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000029803 blastocyst development Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 230000008645 cold stress Effects 0.000 description 1
- 210000001771 cumulus cell Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 231100000557 embryo loss Toxicity 0.000 description 1
- 230000004049 epigenetic modification Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000012165 high-throughput sequencing Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000007659 motor function Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 230000007971 neurological deficit Effects 0.000 description 1
- 230000001936 parietal effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 210000004765 promyelocyte Anatomy 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 208000002254 stillbirth Diseases 0.000 description 1
- 231100000537 stillbirth Toxicity 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 210000004340 zona pellucida Anatomy 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
样本 | WGA浓度值(ng/ul) |
对比例1 | 28.5 |
实施例1 | 46.7 |
循环数 | 温度 | 时间 |
1 | 12℃ | 15min |
1 | 37℃ | 15min |
1 | 72℃ | 20min |
1 | 4℃ | Hold |
循环数 | 温度 | 时间 |
1 | 12℃ | 15min |
1 | 37℃ | 15min |
1 | 72℃ | 20min |
1 | 4℃ | Hold |
STR | 引物1 | 引物2 |
D9S1794 | F1 | R1 |
Vwa | F1 | R1 |
D16S3112 | F1 | R1 |
DXS8098 | F1 | R1 |
染色体 | STR名称 | 培养液样本 | 母方 | 父方 |
Chr.9 | D9S1794 | 149/158/154 | 149/158 | 154/156 |
Chr.12 | Vwa | 222/235/226 | 222/235 | 213/226 |
Chr.16 | D16S3112 | 119/127 | 119/127 | 123/129 |
Chr.X | DXS8098 | 165/167 | 165/167 | 159 |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010164460.3A CN111440857B (zh) | 2020-03-11 | 2020-03-11 | 用于无创胚胎植入前遗传性检测的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010164460.3A CN111440857B (zh) | 2020-03-11 | 2020-03-11 | 用于无创胚胎植入前遗传性检测的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111440857A CN111440857A (zh) | 2020-07-24 |
CN111440857B true CN111440857B (zh) | 2023-03-21 |
Family
ID=71650570
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010164460.3A Active CN111440857B (zh) | 2020-03-11 | 2020-03-11 | 用于无创胚胎植入前遗传性检测的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111440857B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113005195B (zh) * | 2021-04-27 | 2021-12-14 | 北京嘉宝仁和医疗科技有限公司 | 检测携带风险染色体的胚胎的引物组合物、产品及方法 |
CN115807058B (zh) * | 2022-12-02 | 2023-06-30 | 中国科学院水生生物研究所 | 一种低偏向的单精子全基因组扩增方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013052557A2 (en) * | 2011-10-03 | 2013-04-11 | Natera, Inc. | Methods for preimplantation genetic diagnosis by sequencing |
CN105368936B (zh) * | 2015-11-05 | 2021-07-30 | 序康医疗科技(苏州)有限公司 | 一种利用囊胚培养液检测胚胎染色体异常的方法 |
CN105543339B (zh) * | 2015-11-18 | 2021-07-16 | 上海序康医疗科技有限公司 | 一种同时完成基因位点、染色体及连锁分析的方法 |
CN106086199A (zh) * | 2016-07-05 | 2016-11-09 | 上海序康医疗科技有限公司 | 一种利用不含透明带的囊胚培养液检测胚胎染色体异常的方法 |
CN106520940A (zh) * | 2016-11-04 | 2017-03-22 | 深圳华大基因研究院 | 一种染色体非整倍体和拷贝数变异检测方法及其应用 |
CN109536581B (zh) * | 2018-12-29 | 2022-02-01 | 序康医疗科技(苏州)有限公司 | 一种利用囊胚培养液检测胚胎健康状况的方法和产品 |
-
2020
- 2020-03-11 CN CN202010164460.3A patent/CN111440857B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN111440857A (zh) | 2020-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Capalbo et al. | Diagnostic efficacy of blastocoel fluid and spent media as sources of DNA for preimplantation genetic testing in standard clinical conditions | |
CN105368936B (zh) | 一种利用囊胚培养液检测胚胎染色体异常的方法 | |
KR101781147B1 (ko) | 대립유전자, 게놈 및 전사체 검출을 위한 방법 및 유전자형 분석 패널 | |
CN113286892B (zh) | 一种利用囊胚培养液检测胚胎健康状况的方法和产品 | |
Takeuchi | Pre‐implantation genetic testing: past, present, future | |
US20170002414A1 (en) | Preimplantation assessment of embryos through detection of free embryonic dna | |
WO2018006706A1 (zh) | 一种利用不含透明带的囊胚培养液检测胚胎染色体异常的方法 | |
CN113436680B (zh) | 一种同时鉴别胚胎染色体结构异常和致病基因携带状态的方法 | |
CN111440857B (zh) | 用于无创胚胎植入前遗传性检测的方法 | |
Milachich | New advances of preimplantation and prenatal genetic screening and noninvasive testing as a potential predictor of health status of babies | |
Tutt et al. | Analysis of bovine blastocysts indicates ovarian stimulation does not induce chromosome errors, nor discordance between inner-cell mass and trophectoderm lineages | |
CN109920479B (zh) | 一种鉴别胚胎染色体倒位携带状态的方法 | |
Findlay | Pre-implantation genetic diagnosis | |
Holzgreve et al. | Fetal cells in cervical mucus and maternal blood | |
CN114480610A (zh) | 一种检测隐匿性平衡易位携带者胚胎中易位片段单体或三体的方法 | |
Peippo et al. | Birth of correctly genotyped calves after multiplex marker detection from bovine embryo microblade biopsies | |
CN115678964B (zh) | 基于胚胎培养液的植入前胚胎的无创筛选方法 | |
CN116515965A (zh) | 一种筛选具有优良发育潜能胚胎的无创检测方法 | |
CN115938481A (zh) | 一种基于靶向捕获和序列随机测序的通用型胚胎遗传变异检测技术方法和系统 | |
CN114480609A (zh) | 一种鉴别染色体插入易位携带胚胎和正常胚胎的方法 | |
CN114032619B (zh) | 一种用于构建游离dna文库的试剂及其应用 | |
Sesina et al. | Detection of DNA in Human Blastocyst Cavity Aspirate by Multiplex PCR | |
CN113881761A (zh) | 一种用于鉴定胚胎染色体性别的引物和探针及其应用 | |
Tian et al. | Preimplantation genetic testing in the current era, a review | |
Li et al. | Whether the log-likelihood ratio-based IVF-PGTA assay is a more efficient method? |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 350108 floor 1, block a, jiuce building, Haixi hi tech Industrial Park, Fuzhou hi tech Zone, Fujian Province Patentee after: Fujian Aji'an Biotechnology Co.,Ltd. Country or region after: China Address before: 350108 floor 1, block a, jiuce building, Haixi hi tech Industrial Park, Fuzhou hi tech Zone, Fujian Province Patentee before: RGI (FUZHOU) GENETIC MEDICINE LABORATORY Co.,Ltd. Country or region before: China |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: Floor 7, Building 16, Phase II, Innovation Park, No.7 Wulongjiang Middle Avenue, High tech Zone, Fuzhou City, Fujian Province, 350108 Patentee after: Fujian Aji'an Biotechnology Co.,Ltd. Country or region after: China Address before: 350108 floor 1, block a, jiuce building, Haixi hi tech Industrial Park, Fuzhou hi tech Zone, Fujian Province Patentee before: Fujian Aji'an Biotechnology Co.,Ltd. Country or region before: China |
|
CP03 | Change of name, title or address |